Orthopediatrics Corp KIDS
We take great care to ensure that the data presented and summarized in this overview for ORTHOPEDIATRICS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding KIDS
View all-
Brown Advisory Inc1.89MShares$31.7 Million0.05% of portfolio
-
Black Rock Inc. New York, NY1.28MShares$21.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.11MShares$18.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.11MShares$18.5 Million1.18% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.08MShares$18.1 Million0.86% of portfolio
-
Wellington Management Group LLP Boston, MA1.02MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA961KShares$16.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny944KShares$15.8 Million0.01% of portfolio
-
Granahan Investment Management, LLC Waltham, MA760KShares$12.7 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX720KShares$12 Million0.0% of portfolio
Latest Institutional Activity in KIDS
Top Purchases
Top Sells
About KIDS
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Insider Transactions at KIDS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2025
|
Kelly Laine Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,345
+50.0%
|
-
|
|
Aug 21
2025
|
Fred Hite COO and CFO |
BUY
Open market or private purchase
|
Direct |
5,076
+2.33%
|
$96,444
$19.41 P/Share
|
|
May 23
2025
|
(Reynolds) Marie C Infante Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+29.83%
|
-
|
|
May 23
2025
|
Bryan W Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+28.35%
|
-
|
|
May 23
2025
|
Jimmy Duane Mc Donald Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+39.01%
|
-
|
|
May 23
2025
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+23.99%
|
-
|
|
May 23
2025
|
Harold Ruf Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+50.0%
|
-
|
|
May 23
2025
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+29.15%
|
-
|
|
May 23
2025
|
David R Pelizzon Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+20.32%
|
-
|
|
May 23
2025
|
George Sinclair Mitchell Dyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+39.01%
|
-
|
|
May 23
2025
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,401
+4.77%
|
-
|
|
Mar 18
2025
|
David R Bailey President and CEO |
SELL
Open market or private sale
|
Direct |
6,620
-2.03%
|
$158,880
$24.86 P/Share
|
|
Mar 18
2025
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
5,310
-4.57%
|
$127,440
$24.86 P/Share
|
|
Mar 18
2025
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
6,443
-3.0%
|
$154,632
$24.86 P/Share
|
|
Mar 18
2025
|
Joseph W Hauser Pres. Trauma & Def. Correction |
SELL
Open market or private sale
|
Direct |
5,300
-3.71%
|
$127,200
$24.86 P/Share
|
|
Mar 18
2025
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
5,359
-3.48%
|
$128,616
$24.86 P/Share
|
|
Mar 15
2025
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
97,496
+23.03%
|
-
|
|
Mar 15
2025
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
38,773
+25.04%
|
-
|
|
Mar 15
2025
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
63,342
+22.8%
|
-
|
|
Mar 15
2025
|
Joseph W Hauser Pres. Trauma & Def. Correction |
BUY
Grant, award, or other acquisition
|
Direct |
52,169
+26.74%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 371K shares |
|---|---|
| Open market or private purchase | 5.08K shares |
| Bona fide gift | 1.5K shares |
|---|---|
| Open market or private sale | 29K shares |